INTRODUCTION
============

Otitis media (OM) is a generic term for all inflammatory changes originating in the middle ear cavity. OM is encountered in many forms with different onset times and clinical and pathological findings. OM is caused by multiple actions of diverse factors, but mainly develops due to eustachian tube dysfunction or microbial infection. Pathohistological findings in OM include changes in the epithelial cells and subepithelial tissues of the middle ear cavity with osteoclasis and bone resorption of bony structures \[[@b1-ceo-2018-00472]\]. More specifically, the major pathohistological findings of chronic otitis media (COM) include irreversible changes, such as granulation tissue formation, cholesterol granuloma with cholesteatoma, fibrosis, bony destruction, and these changes depend on whether COM is active or inactive \[[@b2-ceo-2018-00472],[@b3-ceo-2018-00472]\].

Otorrhea is one of the most common symptoms observed in COM patients. In most cases, COM is accompanied by intermittent otorrhea, but continuous active otorrhea may occur in perforated OM accompanied by acute infection. Clinical manifestations of otorrhea vary depending on the severity of inflammation \[[@b4-ceo-2018-00472],[@b5-ceo-2018-00472]\]. Furthermore, it has been suggested middle ear effusion and ejection dysfunction derived from OM might be associated with aquaporin (AQP) dysfunctions, which are known to contribute to the control of water homeostasis \[[@b6-ceo-2018-00472]\]. AQP expressions in the middle ear and eustachian tube in the presence of OM has been investigated in animals and humans \[[@b7-ceo-2018-00472]-[@b11-ceo-2018-00472]\], but no study has yet addressed AQP expression levels in COM patients or the role of AQPs in relation to COM. Accordingly, in the present study, we explored whether AQP 1, 2, 3, 4, 5, 6, 8, and 10 mRNAs are considered to be related to OM, are expressed in tissues of the middle ear cavity in COM, and whether their expressions are related to clinical manifestations. In addition, we also investigated the relation between AQP expression and the development of otorrhea.

MATERIALS AND METHODS
=====================

Subjects
--------

The study subjects were 81 patients who visited the Department of Otorhinolaryngology-Head and Neck Clinic of Kyung Hee University Medical Center from May 2015 to August 2017. Patients who visited the center for symptoms such as hearing loss, otorrhea, tinnitus, otalgia, or dizziness of more than 3 months and diagnosed with a perforated tympanic membrane (TM) with or without otorrhea, those with abnormal lesions in the middle ear and mastoid cavity as determined by temporal bone computed tomography, and those with granulation tissues and chronic inflammation based on biopsy finding conducted during surgery, were defined as COM patients. Particular attention was paid to the identification of the origin of otorrhea development in TMs or external auditory canals using otoscope or endoscope and by referring to patient complaints. In patients with hearing loss, pure tone audiometry (PTA) was performed to measure hearing thresholds, and bacterial culture tests were conducted for patients with otorrhea. Before study commencement, written informed consent was obtained from patients, parents, or guardians with respect to the use patient samples after providing an explanation of study purposes. Patients suspected of having acute otitis media (AOM), head or neck anomaly, systemic disease, or congenital or acquired immune deficiencies were excluded. This cross-sectional study was approved by the Institutional Review Board of Kyung Hee University Medical Center (IRB No. 2017-12-030).

Bacterial culture
-----------------

When otorrhea was detected in COM patients, relevant samples were collected and bacterial culture was performed. After cleaning the external auditory canal, otorrhea samples were collected under aseptic conditions using sterilized cottons and an antiseptic otoscope to prevent contact with the external auditory canal. All clinical samples were collected using sterile cotton swabs (Xomed Trace Products, Jacksonville, FL, USA), which were immediately immersed in Stuart transport medium. Solid blood agar and liquid thioglycollate medium (Hangang, Gunpo, Korea) were inoculated with these swabs and then incubated for 24 hours at 35.8ºC. Colony-forming bacteria were identified by Gram stain and biochemical tests.

RNA extraction and real-time PCR
--------------------------------

Total RNA was purified from patient tissue samples using TRIzol solution, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). RNAs were isolated using a RNeasy mini kit (Qiagen, Hilden, Germany). First-strand complementary DNA (cDNA) synthesis was performed with 1 μg of total RNA, which was transcribed to cDNA using a reverse transcription system and random hexamers (Promega, Madison, WI, USA), according to the manufacturer's instructions. To obtain primer sequences, we referred to previous studies ([Table 1](#t1-ceo-2018-00472){ref-type="table"}) \[[@b6-ceo-2018-00472]-[@b11-ceo-2018-00472]\]. Real-time PCR was performed using the StepOnePlus real-time PCR system and Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). PCR reactions were performed with 1 μL of cDNA in a 20 μL reaction mixture containing 10 μL of Power SYBR Green PCR Master Mix, 2 μL of primers, and 7 μL of PCR-grade water. Initial denaturation was conducted at 95°C for 10 minutes and was followed by 40 amplification cycles of 95°C for 15 seconds and 60°C for 1 minute. The crossing points of target genes with β-actin were calculated using the formula 2^--(target\ gene--β-actin)^ and the natural logarithm was used in all logarithmic transformations. Real-time PCR was performed twice and their average value was obtained.

Evaluation of hearing level and type of hearing loss
----------------------------------------------------

PTA was performed by measuring air conduction (AC) and bone conduction (BC), and hearing levels were calculated as the average of three frequencies (500, 1,000, and 2,000 Hz). Based on PTA results, types of hearing loss were classified as either conductive hearing loss (CHL) or sensorineural hearing loss (SNHL). Patients with decreased AC and normal BC, an air-bone gap (ABG) \>10 dB HL, and a negative Rinne test were diagnosed as having CHL; whereas patients with similar decreases in AC and BC, or ABG ≤10 dB HL, and with a positive Rinne test were diagnosed as having SNHL \[[@b12-ceo-2018-00472]\].

Statistical analysis
--------------------

The analysis was conducted using IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA). Results are expressed using descriptive statistics as means and standard deviations, frequencies, or percentages. The Kolmogorov-Smirnov test was used to determine numerical variables were normally distributed. The significances of intergroup differences were determined using the student *t*-test, the Mann-Whitney *U*-test, or the Kruskal-Wallis test followed by post hoc comparisons (Tukey's honest significant difference test and the Bonferroni-adjusted Mann-Whitney test). Statistical significance was accepted for *P*-values \<0.05.

RESULTS
=======

Demographic and clinical characteristics
----------------------------------------

Eighty-one patients diagnosed with COM were enrolled in this study. No differences were found between the otorrhea and non-otorrhea groups with regard to age, sex, duration of illness, affected side, or levels of hearing loss (*P*\>0.05). However, the rate of SNHL was higher in the otorrhea group (*P*=0.020) ([Table 2](#t2-ceo-2018-00472){ref-type="table"}).

Comparison of the mRNA expressions of AQP 1, 2, 3, 4, 5, 6, 8, and 10
---------------------------------------------------------------------

AQP 1, 2, 3, 4, 5, 6, 8, and 10 mRNAs were expressed in inflammatory tissues obtained from the 81 study subjects. AQP 5 mRNA was most predominantly expressed, followed by AQP 3, 1, 10, 6, 8, 2, and 4 in decreasing order ([Table 3](#t3-ceo-2018-00472){ref-type="table"}).

Comparison of the mRNA expressions of AQP 1, 2, 3, 4, 5, 6, 8, and 10 mRNAs in the two study groups
---------------------------------------------------------------------------------------------------

AQP expressions were noticeably lower in the otorrhea group than in the non-otorrhea group, and the expressions of AQP 4 and 6 mRNAs were significantly lower (*P*\<0.05) ([Fig. 1](#f1-ceo-2018-00472){ref-type="fig"}).

Relations between the mRNA expressions of AQP 1, 2, 3, 4, 5, 6, 8, and 10 and hearing loss type and severity
------------------------------------------------------------------------------------------------------------

The 81 study subjects were divided into CHL and SNHL groups based on the results of PTA. AQP expressions were found to be higher in the CHL group than in the SNHL group, but not significantly so (*P*\>0.05) ([Table 4](#t4-ceo-2018-00472){ref-type="table"}). Similarly, the study subjects were divided into ≤40 dB and \>40 dB groups based on serviceable hearing levels. There were no differences of AQP expressions in these two groups (*P*\>0.05) ([Table 5](#t5-ceo-2018-00472){ref-type="table"}).

DISCUSSION
==========

The incidence of OM is very high and the prevalence of COM is dependent on endogenic and exogenic factors. The former includes genetic, racial, and sex- and age-related factors, and the latter environmental, social, and cultural factors. In most cases, AOM can be cured without after effects, but in some recurrent OM or OM with effusion (OME) inflammation persists or reoccurs. Furthermore, even after treatment, AOM can become chronic due to incomplete cure of inflammation in the middle ear cavity. However, the factors responsible for the development of chronic inflammation after acute infections of the middle ear and mastoid cavity have not been elucidated \[[@b1-ceo-2018-00472]-[@b5-ceo-2018-00472]\].

In a recent study, it was concluded water and electrolyte channel proteins in the middle ear mucous membrane contribute to the generation or elimination of fluid in the middle ear \[[@b6-ceo-2018-00472]\]. With regard to the defensive role of mucous epithelium of the middle ear and eustachian tube, homeostasis of mucosal and pericilliary fluid layers produced by ciliated and goblet cells should be maintained, and to achieve this water must be appropriately controlled \[[@b13-ceo-2018-00472]\]. Changes in the amount of water in the middle ear mucous membrane and in electrolyte compositions can be attributed to causes of middle ear diseases, such as, OM, chronicization, middle ear effusion, and otorrhea, and AQPs are engaged in this modulation of water levels \[[@b14-ceo-2018-00472],[@b15-ceo-2018-00472]\].

It has been reported AQPs are involved in urine concentration, the control of water egress in sweat, ischemia, tumors, edema (caused by viral infection), and during cell migration, metabolic processes, and the transmission of neural information. The AQPs that move only water are AQP 0, 1, 2, 4, 5, 6, and 8. AQP 3, 7, 9, and 10 are called aquaglycoporins as they move glycerol and water, and eight AQP types, that is, AQP 1--6, 8, and 10, have been reported to be expressed in the middle ears of humans and animals \[[@b11-ceo-2018-00472],[@b16-ceo-2018-00472]-[@b19-ceo-2018-00472]\]. Previous studies conducted on human subjects have reported the presence of AQP 5 mRNA in the mucous membranes of OME, AQPs 3 and 10 in the effusion of OME, and AQPs 1, 2, 3, 4, 5, 6, 8, 10, and 11 in normal human middle ear epithelium ([Table 6](#t6-ceo-2018-00472){ref-type="table"}). However, no study has previously determined whether the mRNAs of AQP 1, 2, 3, 4, 5, 6, 8, 10, and 11 are expressed in COM patients. In the present study, we examined relations between the expressions of the mRNAs of AQP1-6, 8, and 10 and the pathophysiology of COM. We found that the mRNAs of AQP 1--6, 8, and 10 were expressed in the granulation tissues of COM patients. These expressions, in decreasing order, were as follows; AQP 5\>3\>1\>10\>6\>8\>2\>4. In a study using murine COM models it was reported the expressions of AQP mRNAs in middle ears were 2.79-fold higher in uninfected ears and 5.40-fold higher in infected ears than in normal controls, and thus, it was suggested inflammation contributes to the upregulations of AQPs \[[@b20-ceo-2018-00472]\]. Similarly, other studies have shown that the mRNAs of AQP 1, 2, 3, 4, 5, 6, 8, 10, and 11 mRNAs are expressed in OME patients. Collectively, these results show inflammation in the middle ear affects the mRNA expressions of AQPs, and that these AQPs play the similar roles in immune response in patients with COM.

Changes in the expression and location of AQPs under specific conditions are associated with many diseases. Furthermore, malfunctions in the processes responsible for the metabolisms of AQPs can cause various diseases. Specifically, a number of studies have indicated that tumors develop and grow more slowly in AQP 1 knockout mice \[[@b21-ceo-2018-00472]\], skin hydration, elasticity, barrier recovery, and wound healing are reduced in AQP 3 knockout mice \[[@b22-ceo-2018-00472]\], migrations of stellate cells are reduced by chemotactic factors, and glial scar formation engaged in restoring injured cerebral tissues was delayed in AQP 4 knockout mice \[[@b23-ceo-2018-00472]\], and sensitivities to light and sound are attenuated in AQP 4 knockout mice \[[@b24-ceo-2018-00472]\]. Interestingly, it has also been shown adipocyte hypertrophy and fat accumulation in AQP 7 knockout mice \[[@b25-ceo-2018-00472]\].

AQPs are expressed in immune cells of the innate and adaptive immune systems in human. If pathogens penetrate and damage the middle ear, ion channels in relevant cells are disrupted, and consequently the functions and expressions of transmembrane AQPs are altered. Such conditions cause abnormal changes in intracellular signals and cell membrane potentials resulting in exudation \[[@b26-ceo-2018-00472]\]. In the present study, it was found that the mRNA expressions of all AQPs were lower in the otorrhea group than in the non-otorrhea group, and those of AQP 4 and 6 were significantly lower. These results are similar to those obtained in other disease conditions and it has been established dysfunctional AQP expressions disrupt the modulations of water and inflammation. Accordingly, our observations suggest that AQPs play a role in the regulation of water levels in the tissues of the middle ear, and that disruption of water homeostasis in middle ear cells due to diminished AQP expression results in the excessive accumulation of water in the middle ear cavity, and thus, persistent otorrhea.

Generally, COM is accompanied by hearing loss, usually CHL, although prolonged or severe inflammation may be accompanied by labyrinthitis, which leads to mixed hearing loss or SNHL. Level of hearing loss are determined by the sizes and locations of TM perforations and the states and motilities of ossicular chains \[[@b27-ceo-2018-00472]\]. Furthermore, ossicular lesions are dependent on the type of COM and the presence or absence of otorrhea. In other words, ossicular lesions are encountered more frequently in active COM with otorrhea than in inactive COM without otorrhea \[[@b28-ceo-2018-00472]\]. However, the relation between hearing loss and AQPs have not been explored in animals or humans. In the present study, we compared the expressions of AQP mRNAs with respect to hearing loss type and level, to determine whether AQP expressions are dependent on the level, type, and presence of hearing loss and whether the presence of SNHL is dependent on the expressions of specific AQP mRNAs. However, contrary to our expectations, the results obtained were not statistically significant.

The present study has several limitations that warrant mention. First, for ethical reasons, we were not able to incorporate healthy ears as controls. Second, we measured AQP mRNA levels and not protein levels, and thus, we are unable to comment on the expressions of AQP proteins. Third, in the patients who were classified as non-otorrhea group because of the absence of otorrhea in external auditory canals, inflammation and otorrhea were found in the middle ears and mastoid cavity during surgery. Fourth, antibiotics had been administered before surgery to members of the both otorrhea and non-otorrhea groups, and this may have altered the mRNA expressions of AQPs.

In conclusion, the present study shows the mRNAs of AQP 1, 2, 3, 4, 5, 6, 8, and 10 are associated with the development of COM, and that in patients with COM and otorrhea, the mRNA expressions of AQP 4 and 6 are significantly decreased. Our results suggest the mRNA expressions of AQPs influence the development of otorrhea in COM patients.

HIGHLIGHTS
==========

▪ Aquaporin (AQP) 1, 2, 3, 4, 5, 6, 8, and 10 mRNAs were expressed in inflammatory tissues obtained from all 81 patients with chronic otitis media with or without otorrhea.

▪ AQP 4 (*P*=0.035) and 6 (*P*=0.085) mRNA levels were significantly lower in the otorrhea group.

▪ AQP 4 and 6 mRNAs reduction have an effect on the clinical manifestations of chronic otitis media.
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###### 

Primer sequences used for real-time PCR

  Name      Direction   Sequence                         Product size (bp)
  --------- ----------- -------------------------------- -------------------
  AQP1      Forward     5´-TGGACACCTCCTGGCTATTG-3´       164
            Reverse     5´-GGGCCAGGATGAAGTCGTAG-3´       
  AQP2      Forward     5´-CACCCCTGCTCTCTCCATA-3´        139
            Reverse     5´-GAAGACCCAGTGGTCATCAAAT-3´     
  AQP3      Forward     5´-TCAATGGCTTCTTTGACCAGTTCA-3´   389
            Reverse     5´-CTTCACATGGGCCAGCTTCACATT-3´   
  AQP4      Forward     5´-GAAGGCATGAGTGACAGACC-3´       130
            Reverse     5´-ATTCCGCTGTGACTGCTTTC-3´       
  AQP5      Forward     5´-GCCACCTTGTCGGAATCTAC-3´       148
            Reverse     5´-TAAAGGATGGCAGCCAGGAC-3´       
  AQP6      Forward     5´-CACCTCATTGGGATCCACTT-3´       147
            Reverse     5´-GTTGTAGATCAGTGAGGCCA-3´       
  AQP8      Forward     5´-GTGCCTGTCGGTCATTGAG-3´        125
            Reverse     5´-CAGGGTTGAAGTGTCCACC-3´        
  AQP10     Forward     5´-GCCTGGGAACAACAGTCATT-3´       155
            Reverse     5´-TGAGAAGCCTGAGTCCTGGT-3´       
  β-Actin   Forward     5´-GCGAGAAGATGACCCAGATC-3´       77
            Reverse     5´-GGATAGCACAGCCTGGATAG-3´       

PCR, polymerase chain reaction; AQP, aquaporin.

###### 

Demographic and clinical characteristics according to presence or absence of otorrhea in COM patients

  Variable                         COM with otorrhea (n=53)    COM without otorrhea (n=28)   *P*-value
  -------------------------------- --------------------------- ----------------------------- --------------------------------------------------------
  Age (yr)                         55.5±12.7                   57.5±16.2                     0.536
  Male:female                      23 (43.4):30 (56.6)         9 (32.1):19 (67.9)            0.331
  Disease onset (mo)               54.9±106.9                  43.9±60.5                     0.187
  Affected side, Rt:Lt:both        24:18:11 (45.3:34.0:20.8)   11:10:7 (39.3:35.7:25.0)      0.729
  Presence of bacteria             23 (43.4)                   5 (17.9)                      0.014^[\*](#tfn1-ceo-2018-00472){ref-type="table-fn"}^
  Type of healing loss, CHL:SNHL   30 (56.6):23 (43.4)         22 (78.6):6 (21.4)            0.020^[\*](#tfn1-ceo-2018-00472){ref-type="table-fn"}^
  PTA, AC (dB)                     56.5±22.1                   54.1±20.4                     0.627
  PTA, BC (dB)                     27.9±17.9                   26.0±17.6                     0.640

Values are presented as mean±standard deviation or number (%).

COM, chronic otitis media; Rt, right; Lt, left; CHL, conductive hearing loss; SNHL, sensorineural hearing loss; PTA, pure tone audiometry; AC, air conduction; BC, bone conduction.

*P*\<0.05.

###### 

Comparison of expression of AQP 1, 2, 3, 4, 5, 6, 8, and 10 mRNAs

  Type of AQP   Relative mRNA expression level
  ------------- --------------------------------
  AQP 1         --4.044±2.145
  AQP 2         --5.828±4.463
  AQP 3         --3.623±4.367
  AQP 4         --6.685±2.617
  AQP 5         --3.492±2.075
  AQP 6         --5.695±3.133
  AQP 8         --6.765±2.444
  AQP 10        --4.514±3.107

Values are presented as mean±standard deviation.

AQP, aquaporin.

###### 

Comparison of expression of AQP1, 2, 3, 4, 5, 6, 8, and 10 mRNAs according to types of hearing loss

  Type of AQP   CHL (n=52)      SNHL (n=29)     *P*-value
  ------------- --------------- --------------- -----------
  AQP 1         --3.748±2.206   --4.554±1.931   0.196
  AQP 2         --4.809±4.531   --7.874±3.601   0.397
  AQP 3         --2.584±4.205   --5.292±4.255   0.137
  AQP 4         --5.923±3.089   --7.600±3.334   0.383
  AQP 5         --3.754±2.272   --3.065±1.742   0.251
  AQP 6         --4.989±3.314   --7.082±2.195   0.387
  AQP 8         --6.813±2.290   --8.080±2.573   0.447
  AQP 10        --3.967±3.253   --5.671±2.565   0.377

Values are presented as mean±standard deviation.

AQP, aquaporin; CHL, conductive hearing loss; SNHL, sensorineural hearing loss.

###### 

Comparison of expression of AQP1, 2, 3, 4, 5, 6, 8, and 10 mRNAs according to severity of hearing loss

  Type of AQP   PTA             *P*-value       
  ------------- --------------- --------------- -------
  AQP 1         --3.604±2.627   --4.341±1.844   0.238
  AQP 2         --7.374±3.567   --4.773±4.439   0.687
  AQP 3         --2.686±4.385   --4.018±4.307   0.494
  AQP 4         --6.655±2.426   --6.711±2.926   0.436
  AQP 5         --3.710±2.211   --3.432±2.203   0.285
  AQP 6         --5.029±3.494   --6.065±3.020   0.600
  AQP 8         --7.923±2.531   --5.793±1.892   0.458
  AQP 10        --4.146±3.073   --4.694±3.243   0.420

Values are presented as mean±standard deviation.

AQP, aquaporin; PTA, pure tone audiometry.

###### 

The studies of expression of AQPs in middle ear and eustachian tube

  AQP                    Tissue type   Detection method   Study           
  ---------------------- ------------- ------------------ ------- --- --- -----------------------------------------
  5                                    ○                              ○   Samuel et al. \[[@b17-ceo-2018-00472]\]
  3,10                                                    ○           ○   Jin et al. \[[@b11-ceo-2018-00472]\]
  1,2,3,4,5,6, 8,10,11   ○                                            ○   Seo and Choi \[[@b18-ceo-2018-00472]\]
  1,3,5                  ○                                        ○       Seo and Choi \[[@b18-ceo-2018-00472]\]

AQP, aquaporin; NHMEE, normal human middle ear epithelium; OME-M, mucosa of middle ear cavity from patients with otitis media with effusion; OME-E, effusion of middle ear cavity from patients with otitis media with effusion; IHC, immunohistochemistry; qPCR, quantitative real-time polymerase chain reaction.
